- Dr. Reddy's Laboratories (NYSE:RDY) launches its generic version of Sanofi Genzyme's leukemia med Clolar (clofarabine injection) in the U.S. According to IQVIA, the market is ~$53M.
- Mylan N.V. launched its generic version last week.
Dr. Reddy's launches generic Clolar in U.S.
Recommended For You
More Trending News
About RDY Stock
Related Stocks
Symbol | Last Price | % Chg |
---|---|---|
RDY | - | - |
Dr. Reddy's Laboratories Limited |